These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Interpretation of resistance assay results. Miller V Antivir Ther; 2001; 6 Suppl 2():1-9. PubMed ID: 11678473 [No Abstract] [Full Text] [Related]
6. Antiretroviral resistance. Geretti AM J HIV Ther; 2006 Dec; 11(4):72-3. PubMed ID: 17578209 [No Abstract] [Full Text] [Related]
7. Clinical utility of testing human immunodeficiency virus for drug resistance. Harrigan PR; Côté HC Clin Infect Dis; 2000 Jun; 30 Suppl 2():S117-22. PubMed ID: 10860895 [TBL] [Abstract][Full Text] [Related]
8. Current insights into reverse transcriptase inhibitor-associated resistance. Wainberg MA; White AJ Antivir Ther; 2001; 6 Suppl 2():11-9. PubMed ID: 11678474 [No Abstract] [Full Text] [Related]
9. The role of resistance testing in clinical trial design and product labelling: a regulatory perspective. Laessig KA; Murray JS; Chikami G Antivir Ther; 2000 Mar; 5(1):77-83. PubMed ID: 10846597 [TBL] [Abstract][Full Text] [Related]
10. Predicting antiretroviral drug resistance from the latest or the cumulative genotype. Garcia F; Alvarez M; Fox Z; Garcia-Diaz A; Guillot V; Johnson M; Chueca N; Phillips A; Hernández-Quero J; Geretti AM Antivir Ther; 2011; 16(3):373-82. PubMed ID: 21555820 [TBL] [Abstract][Full Text] [Related]
11. Updated European recommendations for the clinical use of HIV drug resistance testing. Vandamme AM; Sönnerborg A; Ait-Khaled M; Albert J; Asjo B; Bacheler L; Banhegyi D; Boucher C; Brun-Vézinet F; Camacho R; Clevenbergh P; Clumeck N; Dedes N; De Luca A; Doerr HW; Faudon JL; Gatti G; Gerstoft J; Hall WW; Hatzakis A; Hellmann N; Horban A; Lundgren JD; Kempf D; Miller M; Miller V; Myers TW; Nielsen C; Opravil M; Palmisano L; Perno CF; Phillips A; Pillay D; Pumarola T; Ruiz L; Salminen M; Schapiro J; Schmidt B; Schmit JC; Schuurman R; Shulse E; Soriano V; Staszewski S; Vella S; Youle M; Ziermann R; Perrin L Antivir Ther; 2004 Dec; 9(6):829-48. PubMed ID: 15651743 [TBL] [Abstract][Full Text] [Related]
12. Impact of genotypic resistance testing on selection of salvage regimen in clinical practice. Haupts S; Ledergerber B; Böni J; Schüpbach J; Kronenberg A; Opravil M; Flepp M; Speck RF; Grube C; Rentsch K; Weber R; Günthard HF; Antivir Ther; 2003 Oct; 8(5):443-54. PubMed ID: 14640392 [TBL] [Abstract][Full Text] [Related]
13. Genotypic resistance tests for the clinical management of patients with primary HIV infection. Narciso P; Lazzarin A Scand J Infect Dis Suppl; 2003; 106():66-70. PubMed ID: 15000588 [TBL] [Abstract][Full Text] [Related]